-
1 Comment
Pharmesis International Ltd is currently in a long term downtrend where the price is trading 10.0% below its 200 day moving average.
From a valuation standpoint, the stock is 92.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
Pharmesis International Ltd's total revenue rose by 128.1% to $27M since the same quarter in the previous year.
Its net income has increased by 73.4% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 300.2% to $588K since the same quarter in the previous year.
Based on the above factors, Pharmesis International Ltd gets an overall score of 4/5.
| Exchange | SG |
|---|---|
| ISIN | None |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | SGD |
| Market Cap | 11M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | -1.17 |
Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs. The company offers Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for rheumatoid arthritis and other rheumatic diseases treatment. It also provides Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice and clear heat toxin; Shulinghou for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Fu Yang for the treatment skin pruritus and urticaria; and Xiong Dan Chuan Bei for the treatment of phlegm and cough. Further, the company distributes chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. The company provides western medicine products under the Kinna brand name; and TCM formulated products under the Longlife brand name. Pharmesis International Ltd. was founded in 1996 and is based in Singapore.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BFK.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
